Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.9 BRL | -16.11% | -1.56% | -13.54% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company has a low valuation given the cash flows generated by its activity.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- Low profitability weakens the company.
- One of the major weak points of the company is its financial situation.
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-13.54% | 2.88B | C+ | ||
+2.46% | 102B | A- | ||
-8.98% | 60.79B | A- | ||
+74.76% | 48.86B | B | ||
+13.97% | 37.96B | B | ||
+4.56% | 32.37B | A- | ||
+14.72% | 20.64B | B- | ||
+11.17% | 16.58B | C+ | ||
+8.81% | 13.93B | B- | ||
-3.19% | 13.25B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BRKM5 Stock
- Ratings Braskem S.A.